BP000027-CYT-200: Recombinant Human VEGF (121 a.a.) Protein, Sf9
Source: Sf9, Insect Cells-derived.
Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 2-5 ug/ml corresponding to a Specific Activity of 200,000-500,000 IU/mg.
Purity: >90% by SDS-PAGE and RP-HPLC.BP000027-CYT-225: Recombinant Human Vascular Endothelial Growth Factor (VEGF) Protein, HEK
Source: HEK 293 (Human Embryonic Kidney cell line)-derived.
Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 1-6 ug/ml corresponding to a Specific Activity of 166,667-1,000,000 IU/mg.
Purity: > 95% by SDS-PAGE.BP000027-CYT-226: Recombinant Mouse Vascular Endothelial Growth Factor (VEGF) Protein, Sf9
Source: Baculovirus Sf9 cells-derived.
The ED50 range, determined by the dose-dependent proliferation of human umbilical vein endothelial cells (HUVEC) (measured by 3H-thymidine uptake) is 1-2 ug/ml, corresponding to a specific activity of 1x106 Units/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000027-CYT-241: Recombinant Human Vascular Endothelial Growth Factor (VEGF) Protein
Source: E. coli-derived.
Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 1-8 ug/ml corresponding to a Specific Activity of 125,000-1,000,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000311-PRO-468: Recombinant Human CD2
Source: E. Coli-derived.
Applications: ELISA; Inhibition Assays; WB.BP000322-CYT-125: Recombinant Human FAS
Source: E.coli-derived.
The ED50 was determined by its ability to inhibit the cytotoxicity of Jurkat cells is between 10-15 ug/ml in the presence of 2 ug/ml of hFasL.
Purity> 95%, by SDS-PAGE and RP-HPLC.BP000322-PRO-594: Recombinant Human FAS His Tag
Source: E.coli-derived.
Purity> 95%, by SDS-PAGE and RP-HPLC.BP000337-HOR-305: Human GLP-2
Purity > 95%, by RP-HPLC.BP000427-HIV-132: Recombinant HIV Type-O Envelope
Source: E. coli-derived.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000427-HIV-133: Recombinant HIV Type-O gp41
Source: E. coli-derived.
Purity > 90%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.